Furthermore, pre-existing RPE atrophy and disruption in the ELM are described to serve as predictors for an early poor visual response to anti-vascular endothelial growth factor (anti-VEGF) treatment in nAMD (7). The gene discussed is VEGFA; the disease is Atrophy.